[HTML][HTML] Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …
[HTML][HTML] Steatotic liver disease: metabolic dysfunction, alcohol, or both?
K Staufer, RE Stauber - Biomedicines, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), both of
them accounting for fatty liver disease (FLD), are among the most common chronic liver …
them accounting for fatty liver disease (FLD), are among the most common chronic liver …
MetALD: new opportunities to understand the role of alcohol in steatotic liver disease
For many years non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease
(ALD) have been considered as two biologically and clinically distinct conditions. According …
(ALD) have been considered as two biologically and clinically distinct conditions. According …
Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease
Importance Metabolic dysfunction–associated steatotic liver disease (MASLD) is currently
the most common chronic liver disease worldwide. It is important to develop noninvasive …
the most common chronic liver disease worldwide. It is important to develop noninvasive …
Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting
Background The long‐term results of web‐based behavioural intervention in non‐alcoholic
fatty liver disease (NAFLD) have not been described in patients followed in specialised …
fatty liver disease (NAFLD) have not been described in patients followed in specialised …
[HTML][HTML] Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know
K Cusi, J Budd, E Johnson, J Shubrook - Diabetes Spectrum, 2024 - Am Diabetes Assoc
Standards of care summarized in clinical practice guidelines for nonalcoholic fatty liver
disease (NAFLD) offer clinicians a streamlined diagnostic and management approach …
disease (NAFLD) offer clinicians a streamlined diagnostic and management approach …
[HTML][HTML] Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
Background & Aims Long-term studies of the prognosis of NAFLD are scarce. Here, we
investigated the risk of major adverse liver outcomes (MALO) in a large cohort of patients …
investigated the risk of major adverse liver outcomes (MALO) in a large cohort of patients …
[HTML][HTML] WFUMB guidelines/guidance on liver multiparametric ultrasound. Part 2: guidance on liver fat quantification
G Ferraioli, RG Barr, A Berzigotti, I Sporea… - Ultrasound in medicine …, 2024 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology (WFUMB) has
promoted the development of this document on multiparametric ultrasound. Part 2 is a …
promoted the development of this document on multiparametric ultrasound. Part 2 is a …
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: a randomised, controlled proof‐of‐concept study
A Armandi, H Bespaljko, A Mang… - Alimentary …, 2024 - Wiley Online Library
Background The current management of metabolic dysfunction‐associated steatotic liver
disease (MASLD) relies on lifestyle intervention. Prior studies have shown that nutritional …
disease (MASLD) relies on lifestyle intervention. Prior studies have shown that nutritional …
[HTML][HTML] Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care
JP Nogueira, K Cusi - Diabetes Spectrum, 2024 - Am Diabetes Assoc
Insulin resistance is implicated in both the pathogenesis of nonalcoholic fatty liver disease
(NAFLD) and its progression from steatosis to steatohepatitis, cirrhosis, and even …
(NAFLD) and its progression from steatosis to steatohepatitis, cirrhosis, and even …